ArticleEpilepsy research2012
Non-linear classification of heart rate parameters as a biomarker for epileptogenesis.
Article in Epilepsy research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 12 citations in OpenAlex.
- Adaptation strategies and neurophysiological response in early-stage Parkinson's disease: BioVRSea approach.Frontiers in human neuroscience · 2023Article
- Analysis of complexity in the EEG activity of Parkinson's disease patients by means of approximate entropy.GeroScience · 2022Article
- Blending Electronics with the Human Body: A Pathway toward a Cybernetic Future.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018Review
- A Brain-Heart Biomarker for Epileptogenesis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018Article
- Complexity of resting-state EEG activity in the patients with early-stage Parkinson's disease.Cognitive neurodynamics · 2017Article
- Investigation of EEG abnormalities in the early stage of Parkinson's disease.Cognitive neurodynamics · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
purposeTo characterize a biomarker for epileptogenesis based on cardiac interbeat interval characteristics.
methodsElectrocardiograph (ECG) and electroencephalogram (EEG) signals were recorded from freely moving rats (n = 23) before status epilepticus (SE) induced by i.p. pilocarpine (PILO) injection as baseline, and on days 1, 3 and 7 after SE. We assessed several features from cardiac interbeat intervals, including linear, non-linear and frequency parameters of interbeat intervals, and power spectra of interpolated intervals during epileptogenesis. After thresholding, the altered values were applied to a non-linear classifier. The non-linear classifier divided animals into two groups; with and without epilepsy, based on all collected data.
resultsWe found that none of the single altered parameters in cardiac activity emerged as a sole biomarker for epileptogenesis. However, the non-linear classifier distinguished animals that later developed from those and did not develop epilepsy. The non-linear classification was performed on preliminary findings from 23 animals; six did not develop epilepsy and the rest did. The average positive predictive value (precision rate) was 78%. This was calculated based on the average sensitivity and specificity, which were 80.6% and 35.2% respectively, for the 100 classification passes. We also showed that these numbers would have increased as the number of subjects increased.
conclusionChanges to the brain caused by status epilepticus that lead to epileptogenesis have systemic effects, and alter cardiac activity. A non-linear classifier performed on several extracted features of cardiac interbeat intervals may be useful as a biomarker to identify animals with low and high probability of developing epilepsy after status epilepticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.